German drug panel backs positive list
The German medical profession's commission on medicines, the AK, haswarned against the possibility that plans to introduce a positive drugs list might founder.
Calling the list an effective counter-measure against irrational prescribing, commission chairman Bruno Muller-Oerlinghausen said that while many doctors prescribe over 1,000 different drugs per quarter, they are insufficiently informed as to their effectiveness. A clear list of target-related drugs would provide more reassurance and independence for doctors in relation to the pharmaceutical industry, he said, adding that this would not jeopardize the quality of the drug supply nor restrict the freedom of doctors to prescribe.
Prof Muller-Oerlinghausen pointed out that the German Doctors' Conference had backed the list and he criticized the campaign being conducted by the pharmaceutical industry association, the BPI, against it.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze